必可酮气雾剂

  • 网络Becotide;BDP
必可酮气雾剂必可酮气雾剂
  1. 目的评价吸入必可酮气雾剂(BDP)对咳嗽变异型哮喘(CVA)的疗效。

    Objective To evaluate the effects of inhaled BDP in patients with CVA .

  2. SD大鼠腹腔注射卵蛋白制成哮喘模型,分别予相应方法治疗,并与必可酮气雾剂比较。

    SD rats were modeled into asthmatic rats by abdominal injection of egg albumin , and then treated by aforementioned methods ;

  3. 吸入激素组在常规治疗基础上,加用二丙酸倍氯米松(必可酮)气雾剂治疗,每天1000μg,连续治疗3个月;

    Group A ( 24 cases ) inhaled glucocorticosteroids ( Becotide ( 1 000 μ g · d ~ ( - 1 )) for three months ) on the base of routine therapy .